Hypertemperature‐Detonated Biomimetic Semiconductor Stromal Bombs for Enhanced Immunotherapy in Pancreatic Cancer
Advanced Materials · 2026-11 · 38 (63)
DOI: 10.1002/adma.202523468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 28.09.2026. Verfasst von Chengke Xie und 22 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou, …. Hauptthemen laut MEDLINE: Immunotherapy, Pancreatic Neoplasms, Biomimetic Materials, Semiconductors. Die Arbeit nennt 65 Literaturangaben. Gefördert von: Leading Talent Project for Scientific and Technological Innovation in Fujian Province, National Natural Science Foundation of China, Fujian Province Science and Technology Innovation Joint Fund Project.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is characterized by “copper avidity”, which easily leads to the dysregulation of copper ion homeostasis. It is possible to develop targeted nanodrugs that selectively kill cancer cells via cuproptosis. However, the dense stroma of PDAC acts as an airtight wall, which not only limits the penetration and distribution of therapeutic agents but also promotes immunosuppressive mechanisms via its hypoxia‐promoting effects, often leading to treatment failure. Thus, we developed a near‐infrared (NIR)‐responsive semiconductor polymer‐metal‒organic framework (MOF) nanoreactor (SPNMCH) that was loaded with copper sulfide nanoclusters (CuS x NCs) and hyaluronidase (HAase). This biomimetic semiconductor “bomb” extensively demolishes the wall (by highly activating HAase) and precisely eliminates tumor cells (through its active copper uptake to induce cuproptosis). Simultaneously, the synergistic effects of increased oxygen delivery and cuproptosis elicit robust antitumor immune responses to inhibit tumor progression and distant metastasis, and strong immune memory effects as observed in four mouse cancer models. Additionally, SPNMCH can be combined with anti‐programmed death receptor 1 (PD‐1) antibodies to further promote T cell‐mediated antitumor immunity. This study reveals a promising strategy for establishing a “hot” tumor immune niche in PDAC to promote the response to immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou, China.
- Department of Hepatobiliary Pancreatic Surgery, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou University, Fuzhou, China.
- Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
- Department of Hepatobiliary-Pancreatic & Hernia Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
- Affiliated Gaozhou People's Hospital, Guangdong Medical University, Gaozhou, China.
- Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
ORCID-Profile: Zibiao Li, Chengyu Liao, Shi Chen
Förderung
- Leading Talent Project for Scientific and Technological Innovation in Fujian Province
- National Natural Science Foundation of China
- Fujian Province Science and Technology Innovation Joint Fund Project
- Natural Science Foundation of Fujian Province
- Agency for Science, Technology and Research
- Fujian Provincial Health Outstanding Contribution Young and Middle-aged Experts Program
- National Science and Technology Major Project for Research on the Prevention and Treatment of Cancer, Cardiovascular and Cerebrovascular Diseases, Respiratory…
- Excellent Young Scholars Project of Natural Science Foundation of Fujian Province
Zitieren
APA
Xie, C., Zhu, H., Wen, J., Mo, Y., Wang, W., Yu Chan, C., Lin, X., Huang, X., Li, G., Wu, Y., Fan, X., Jie, Z., Yan, M., Li, Z., Wang, Z., Heng, J. Z. X., Tang, K. Y., Tian, Y., Ye, E., …, & Chen, S. (2026). Hypertemperature‐Detonated Biomimetic Semiconductor Stromal Bombs for Enhanced Immunotherapy in Pancreatic Cancer. Advanced Materials, 38(63). https://doi.org/10.1002/adma.202523468
Vancouver
Xie C, Zhu H, Wen J, Mo Y, Wang W, Yu Chan C, et al. Hypertemperature‐Detonated Biomimetic Semiconductor Stromal Bombs for Enhanced Immunotherapy in Pancreatic Cancer. Advanced Materials. 2026;38(63). doi:10.1002/adma.202523468
BibTeX
@article{Xie2026,
author = {Xie, Chengke and Zhu, Houjuan and Wen, Jianfan and Mo, Yichao and Wang, Wanwan and Yu Chan, Chui and Lin, Xinquan and Huang, Xiaoxiao and Li, Ge and Wu, Yongding and Fan, Xiaotong and Jie, Zheng and Yan, Maolin and Li, Zhiyuan and Wang, Zuwei and Heng, Jerry Zhi Xiong and Tang, Karen Yuanting and Tian, Yifeng and Ye, Enyi and Jun, Loh Xian and Li, Zibiao and Liao, Chengyu and Chen, Shi},
title = {Hypertemperature‐Detonated Biomimetic Semiconductor Stromal Bombs for Enhanced Immunotherapy in Pancreatic Cancer},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {63},
doi = {10.1002/adma.202523468}
}
EUVIMED